<html>
<head>PUBMED IDs for ECRG2</head>
<body bgcolor='#C5F0F2'><h1>ECRG2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12646258/'>ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis.</a> March 21  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12970870/'>Using yeast two-hybrid system to identify ECRG2 associated proteins and their possible interactions with ECRG2 gene.</a> September 13  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14639608/'>Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population.</a> November 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15857172/'>Monoclonal antibodies to esophageal cancer-related gene2 protein.</a> April 29  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17352218/'>Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.</a> March 14  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17418617/'>Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.</a> April 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17602171/'>ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity.</a> July 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18162463/'>ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.</a> December 29  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18618216/'>Association of ECRG2 TCA short tandem repeat polymorphism with the risk of oesophageal cancer in a North Indian population.</a> July 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18824154/'>Mapping the putative binding site for uPA protein in Esophageal Cancer-Related Gene 2 by heteronuclear NMR method.</a> October 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19717562/'>ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19732125/'>Identification of some human genes oppositely regulated during esophageal squamous cell carcinoma formation and human embryonic esophagus development.</a> September 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19796867/'>ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration.</a> April 8  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21042721/'>Molecular cloning and characterization of a novel esophageal cancer related gene.</a> February 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22315007/'>MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.</a> September 26  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23079671/'>Suppression of hepatocarcinoma model in vitro and in vivo by ECRG2 delivery using adenoviral vector.</a> July 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24701826/'>[Prokaryotic expression, purification and activity analysis of recombinant human serine protease inhibitor Hespintor Kazal Domain].</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24821237/'>Purification and identification of the Kazal domain of a novel serine protease inhibitor, Hespintor, through a bacterial (Escherichia coli) expression system.</a> December 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24821235/'>Renalase gene polymorphism in patients with hypertension and concomitant coronary heart disease.</a> March 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26434587/'>Negative regulation of RNA-binding protein HuR by tumor-suppressor ECRG2.</a> October 6  2015<br></body></html>
